CClinicalTrials.gg
CompletedNCT04033263Updated Sep 23, 2025

Maintaining Oral Health With Bio-products

An interventional study of Mouth rinse 1 and Mouth rinse 2 in Dental Caries and Dental Erosion, sponsored by University of Bern. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-23.

Sponsored by University of Bern · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study will follow a randomised, double-blind, cross-over design. Participants will use mouth rinses containing plant extracts and/or fluoride, as well as a mouth rinse containing only water (placebo). They will use oral appliances containing sterilized enamel and dentine slabs, which will be later collected for analyses.

The cross-over design will allow participants to use all rinses, allowing for a comparison between the rinses within each individual.

Read the detailed description

This study will be made in three in situ parts. Participants will wear an oral appliance containing sterilized enamel and dentine slabs. During this experimental phase, they will use the designated mouth rinse. After this period, the investigators will remove the enamel and dentine slabs, and will also collect salivary pellicle and any bacterial biofilm forming on the participant's teeth. Participants will also donate saliva for proteomic analysis (protein profile) to verify if there are any differences in proteins in saliva to proteins in the pellicle. Throughout the whole study, all participants will use standardized oral hygiene products.

The experimental mouth rinses contain plant extracts that could interact with salivary proteins and influence the salivary pellicle and oral biofilm, thus bringing positive results against tooth (enamel and dentine) demineralisation.

02

Conditions studied

  • Dental Caries
  • Dental Erosion
03

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants will be healthy young adults of both sexes, with normal salivary flow, with no cavitated caries lesions, no gingivitis or periodontal disease, no severe erosive tooth wear, and no other serious general or oral conditions.
  • Participants will have signed an informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Presenting oral diseases or conditions, such as untreated cavitated caries lesions, gingivitis or periodontitis, severe erosive tooth wear, etc.
  • Participants who are under orthodontic treatment (wearing braces),
  • Contraindications to the mouth rinses under study, e.g. known hypersensitivity or allergy to the investigational product,
  • Participants using drugs that cause hyposalivation,
  • Women who are pregnant or breast feeding,
  • Intention to become pregnant during the course of the study,
  • Individuals suffering from clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
  • Participation in another study with investigational drug within the 30 days preceding and during the present study,
  • Enrolment of the investigator, his/her family members, employees and other dependent persons,
  • Specific exclusions for the disease under study,
  • Specific concomitant therapy washout requirements prior to and/or during study participation
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Care provider)
Enrollment
12 participants (actual)

Study arms

  • Placebo comparator
    Placebo mouth rinse

    Placebo: Deionized water (serving as negative control)

    Other: Mouth rinse 1

  • Active comparator
    Elmex mouth rinse

    Commercial mouth rinse used as gold standard in erosion studies: elmex® Erosion Protection solution (which contains 800 ppm Sn2+, as SnCl2, and 500 ppm F-, as NaF and AmF)

    Other: Mouth rinse 2

  • Experimental
    Plant extract A with fluoride

    Plant Extract A + Fluoride

    Other: Mouth rinse 4

  • Active comparator
    Fluoride

    NaF Fluoride Rinse

    Other: Mouth rinse 3

Interventions

  • OtherMouth rinse 1

    Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

    Also known as: Water

  • OtherMouth rinse 2

    Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

    Also known as: Elmex Erosion Protection mouth rinse

  • OtherMouth rinse 3

    Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

    Also known as: Fluoride mouth rinse

  • OtherMouth rinse 4

    Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

    Also known as: Plant extract A and fluoride

05

What researchers measure

Primary outcomes

  1. Enamel mineral loss

    Hardness of enamel slabs (Knoop hardness)

    Time frame: End of the study arm, expected to be after 1 week of using the mouth rinse

  2. Dentine mineral loss

    Profilometry of dentine specimens (step height in µm)

    Time frame: End of the study arm, expected to be after 1 week of using the mouth rinse

Secondary outcomes

  1. Identification of which proteins are present in the participants' saliva

    Proteomic analyses of the saliva (list of proteins present)

    Time frame: End of the study arm, expected to be after 1 week of using the mouth rinse

  2. Identification of which proteins are present in the participants' salivary pellicle

    Proteomic analyses of the salivary pellicle (list of proteins present)

    Time frame: End of the study arm, expected to be after 1 week of using the mouth rinse

  3. Thickness of the salivary pellicle

    Measured using TEM (mineralization measured in Delta Z)

    Time frame: End of the study arm, expected to be after 1 week of using the mouth rinse

  4. pH of the participants' biofilm

    Measured in vivo after using the mouth rinses (pH)

    Time frame: End of the study arm in part 3, expected to be after 1 day of using the mouth rinse

  5. Identification of the bacteria in the biofilm

    Measured after collecting the biofilm (list of bacterial species)

    Time frame: End of the study arm in part 3, expected to be after 1 day of using the mouth rinse

  6. How many bacteria are adhered to the biofilm

    Measured after collecting the biofilm (bacteria quantity)

    Time frame: End of the study arm in part 3, expected to be after 1 day of using the mouth rinse

06

Study locations

1 site
  • Univesity of Bern (Klinik für Zahnerhaltung, Präventiv- und Kinderzahnmedizin)
    Bern, Canton of Bern 3010, Switzerland
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04033263
Lead sponsor
University of Bern
Responsible party
Sponsor
First posted
Jul 26, 2019
Start date
Nov 1, 2024
Primary completion
Jun 30, 2025
Completion
Jun 30, 2025
Last update
Sep 23, 2025

Study contacts

Thiago S Carvalho, PD Dr
principal investigator · University of Bern

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion